The American Chamber of Commerce (AmCham Russia) is one of the leading foreign business associations in Russia, which unites more than 500 major American, European and Russian companies.

On November 26, 2020, Vladimir Khristenko took part in a business breakfast organized by Alexis Rodzianko, President of the American Chamber of Commerce in Russia, and Ekaterina Pogodina, CEO of Johnson & Johnson LLC.

The meeting was attended by the heads of various companies, and members of the American Chamber of Commerce. They discussed the consequences of the pandemic for various fields of business activities, shared their experience in overcoming the challenges faced during lockdown and business transformation. Besides, they dwelled on new trends and possibility of whether they will remain in the future.

Vladimir Khristenko, President of NANOLEK: “Despite the fact that the popular saying, the world will never be the same, wears off a bit, it reflects supremely well what is happening nowadays. We have survived the first wave of the pandemic and learned to live in a new reality, therefore I believe, everything is more quiet now and, most importantly, people’s approach to the pandemic became more constructive.

Pharmaceutics is an industry where no one can relax in whatever the circumstances may be. We bear the responsibility for people’s health. We are fostering all our efforts and staying on the front line. It is important that we have the opportunity to hold such meetings, exchange opinions, and design new trends. It should be noted that all companies, regardless of the type of activities, are heading towards digitalization of businesses, optimization of business processes, and partially revising their strategies. Such communication is conductive to the implementation of joint initiatives with representatives of the leading global corporations.”

We would like to remind that in 2019 NANOLEK and Janssen, a pharmaceutical division of Johnson & Johnson LLC, released a statement that the production of a drug used in the treatment of multiple myeloma was localized in Russia.